10th Translational Research Conference: Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Hematopoiesis

10^th Translational Research Conference:
Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Hematopoiesis

SAVE THE DATE: October 16-18, 2026 – Malahide (Dublin), Ireland *

Chairs: Pierre Fenaux, Katharina Götze, Mikkael Sekeres

#ESHMDS2026

REGISTRATION & ABSTRACT SUBMISSION
ARE OPEN!

ABOUT THE CONFERENCE:

The ESH 10^th Translational Research Conference: Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Hematopoiesis will present the latest updates in some of the basic mechanisms of disease in MDS, MDS/MPN, and precursor conditions, and demonstrate how they are translated into clinical practice. Standards for treatment, timing and sequencing of treatment, and the latest clinical trial data and future directions for therapy will be discussed, along with interventions for clonal hematopoiesis precursor conditions.

Attendees will have the opportunity to learn practical approaches to treating these complicated diseases in a relaxed environment, with ample time provided for patient- and research centered questions, and for networking to create future clinical and research collaborations.

THE PROGRAMME WILL INCLUDE:

– Plenary Sessions
– Panel Discussions
– Roundtables
– Simultaneous Meet the Expert Sessions
– Poster Walks
– Brief Oral Communications
– Ample time for in-depth discussion

LEARNING OBJECTIVES:

– Describe the basic mechanisms of disease in MDS, MDS/MPN, and precursor conditions.
– Demonstrate how the basic mechanisms of myeloid malignancies are translated into clinical practice.
– Describe the treatment approach for lower-risk MDS and MDS/MPN.
– Describe the treatment approach for higher-risk MDS and MDS/MPN.

* This conference is a Face to Face meeting. No virtual attendance is scheduled.

TBA

ABSTRACTS ARE ELIGIBLE TO BE SELECTED FOR BRIEF ORAL COMMUNICATIONS OR POSTER PRESENTATIONS!
Deadline: July 6^th, 2026 (23:59 CEST)

CLICK HERE TO SUBMIT YOUR ABSTRACT

Guidelines for your abstract submission:

1. Your abstract should be structured (e.g. Objectives, Methods, Results, Conclusions)

2. Maximum number of words: 500

3. You abstract will be submitted to the peer review procedure.

We accept “encore” abstract.
Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Grand Hotel Malahide
Grove Road, Malahide, K36XT65 Dublin, Ireland

REGISTRATION IS OPEN!

The registration fee for the ESH 10^th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Hematopoiesis is:

– 600€ for fully trained

– 300€ for in-training *

– 300€ Allied Health Professionals

– 600€ for Corporate

*A proof will be requested to confirm your status.

ESH is pleased to offer BHS, BSH, DGHO, HSH, OeGHO, PTHiT, SEHH, SFH (French), SFH (Swedish) & SPH Members a 20% discount on the conference registration fees.

This fee includes:
– Your seat in the Conference Room
– The conference materials,
– Welcome cocktail, luncheons, refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.

REGISTER HERE